Yhdistynyt kuningaskunta -
englanti -
MHRA (Medicines & Healthcare Products Regulatory Agency)
benzylpenicillin 0.6% eye drops
special order - benzylpenicillin sodium - eye drops - 6mg/1ml
Yhdistynyt kuningaskunta -
englanti -
MHRA (Medicines & Healthcare Products Regulatory Agency)
benzylpenicillin 6% eye drops
special order - benzylpenicillin sodium - eye drops - 60mg/1ml
Yhdistynyt kuningaskunta -
englanti -
MHRA (Medicines & Healthcare Products Regulatory Agency)
benzylpenicillin 0.3% eye drops
special order - benzylpenicillin sodium - eye drops - 3mg/1ml
Zimbabwe -
englanti -
Medicines Control Authority
benzylpenicillin sodium
caps pvt ltd - benzylpenicillin - powder/injectable; injection - 5x10^6 u
Zimbabwe -
englanti -
Medicines Control Authority
benzylpenicillin sodium
umedica - benzylpenicillin - powder/injectable; injection - 5mu
Uganda -
englanti -
National Drug Authority
benzylpenicillin injection 1,000,000i.u parenteral ordinary dry vials
astra pharma (uk) ltd - benzylpenicillin sodium - parenteral ordinary dry vials - 1,000,000i.u
Uganda -
englanti -
National Drug Authority
benzylpenicillin injection 1000000 i.u parenteral ordinary dry vials
royal pharma - benzylpenicillin sodium - parenteral ordinary dry vials - 1000000 i.u
Namibia -
englanti -
Namibia Medicines Regulatory Council
pencillin g sodium sandoz 1 000 000 iu
sandoz sa (pty) ltd - benzylpenicillin sodium - injection - each vial contains benzylpenicillin sodium 1,000.000 iu equivalent to approximately 600 mg
Yhdysvallat -
englanti -
NLM (National Library of Medicine)
diclofenac sodium- diclofenac sodium tablet, delayed release diclofenac sodium- diclofenac sodium tablet
boehringer ingelheim roxane laboratories - diclofenac sodium (unii: qtg126297q) - tablet, delayed release - 50 mg - diclofenac sodium delayed-release tablets are indicated for the acute and chronic treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. diclofenac sodium delayed-release tablets are contraindicated in patients with hypersensitivity to the product. diclofenac should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to diclofenac have been reported in such patients.
Armenia -
englanti -
Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
penicillin-g rs powder for solution for injection
reyoung pharmaceutical co. ltd. - benzylpenicillin (benzylpenicillin sodium) - powder for solution for injection - 1000000iu